Stocks to Watch: Pizza Versus the Gym, Sanofi, Sika

Joe Easton from the equities team discusses Barclays' upgrade of Domino's Pizza and downgrade of Gym Group due to changing consumer trends. Sanofi's Dupixent drug trial shows promising results, potentially boosting sales. Seeker announces an asset sale to Sinven, impacting UK billionaire Jim Ratcliffe's financial position as he negotiates to buy Manchester United.

Why did Barclays analysts upgrade Domino's Pizza to overweight?

• Increased app usage in the UK

• Expansion into new countries

• New pizza flavors introduced

• Partnership with Netflix

What was the main concern for Gym Group according to Barclays analysts?

• High operational costs

• Decline in membership numbers

• Increased competition

• Lack of new gym locations

What is Dupixent used to treat?

• Chronic lung illness

• Heart disease

• Diabetes

• Arthritis

What legal issue affected Sanofi's stock last year?

• Tax evasion

• Merger disputes

• Claims over Zantac

• Patent infringement

Who is potentially using the proceeds from Seeker's asset sale?

• Warren Buffet for Berkshire Hathaway

• Elon Musk for SpaceX

• Jeff Bezos for Blue Origin

• Jim Ratcliffe for Manchester United